Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Stopped early · Phase 3 · Has a placebo group

Conditions studied: Celiac Disease

In brief

To assess the efficacy and safety of larazotide acetate versus placebo for the relief of persistent symptoms in adult celiac disease patients.

Key facts

Study ID
NCT03569007
Run by
9 Meters Biopharma, Inc.
People needed
307
Starts
2019-05-29
Expected to finish
2022-07-21
Last updated by the study team
2022-07-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.